Melissa Scott
Thoracic Surgery (Cardiothoracic Vascular Surgery) · Denison, TXNPI 1740782762
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 152 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 29 manufacturers, the largest accounting for just 14.1% — the pattern of someone who eats at a lot of different presentations. That places this record below the midpoint for thoracic surgery (cardiothoracic vascular surgery) clinicians in TX, where the typical reported total is $5,866.
Across 152 payments — averaging $22.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$473
- Merck$462
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$321
- Abbott$259
- E.r. Squibb & Sons, L.L.C.$237
- Medtronic$197
- plus $1K from 23 others
What the payments were for
- Food & beverage$3,362100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 18 | $473 |
| Merck | 23 | $462 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 16 | $321 |
| Abbott | 11 | $259 |
| E.r. Squibb & Sons, L.L.C. | 10 | $237 |
| Medtronic | 8 | $197 |
| Amgen | 10 | $161 |
| Johnson & Johnson | 8 | $154 |
| Heartflow, Inc. | 3 | $145 |
| Bayer | 6 | $137 |
| Pfizer | 5 | $108 |
| Boehringer Ingelheim | 5 | $104 |
| AstraZeneca | 5 | $91 |
| Scpharmaceuticals Inc. | 5 | $85 |
| Boston Scientific | 3 | $58 |
| Thrombolex, Inc. | 1 | $39 |
| Kiniksa Pharmaceuticals International, PLC | 2 | $39 |
| Cvrx, Inc. | 2 | $38 |
| Surmodics, Inc. | 1 | $35 |
| Sanofi-aventis U.S. LLC | 1 | $27 |
| GSK | 1 | $26 |
| Lexicon Pharmaceuticals, Inc. | 1 | $25 |
| Impulse Dynamics (USA) Inc. | 1 | $23 |
| Edwards Lifesciences | 1 | $23 |
| ZOLL Respicardia, Inc. | 1 | $23 |
| Medicomp Inc | 1 | $22 |
| Mannkind Corporation | 1 | $18 |
| Inari Medical, Inc. | 1 | $17 |
| Kiniksa Pharmaceuticals, Ltd. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LEQVIO$139
How this compares
$3,362 in reported general payments places this provider in the 35th percentile of 424 thoracic surgery (cardiothoracic vascular surgery) providers in Texas.
See all thoracic surgery (cardiothoracic vascular surgery) providers in Texas →
Other thoracic surgery (cardiothoracic vascular surgery) in Denison
- Faraz KerendiAustin$906K
- Robert HebelerDallas$723K
- Michael ReardonHouston$713K
- Danny RamzyHouston$527K
- Scott OlssonCypress$357K
- Randall WolfHouston$283K
- Gary JettPlano$277K
- Darien BradfordBurleson$266K
- William BrinkmanPlano$266K
- Brannon HydeAustin$214K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.